symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
BIAF,1.36,0,10264,12716408,0,0.955-3.99,0.09,"bioAffinity Technologies, Inc.",USD,0001712762,,,NASDAQ Capital Market,NASDAQ,Diagnostics & Research,https://www.bioaffinitytech.com,"bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.",Ms. Maria  Zannes J.D.,Healthcare,US,14,210 698 5334,22211 West Interstate 10,San Antonio,TX,78257,,0,https://financialmodelingprep.com/image-stock/BIAF.png,2022-09-01,False,False,True,False,False
